In CRC, miR-20 influences the activation of the cyclin-dependent kinase inhibitor 1A/p21 (CDKN1A/p21), which negatively regulates TGFβ, thus preventing its antiproliferative effect [286]. The gene discussed is CDKN1A; the disease is colorectal carcinoma.